Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 17028
Country/Region: South Africa
Year: 2015
Main Partner: University of the Witwatersrand
Main Partner Program: Wits Reproductive Health and HIV Institute
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: $3,000,000

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: 15-19 Female 2016 142
CARE_CURR Age/sex: 15-19 Female 2016 142
CARE_CURR Age/sex: 15-19 Male 2016 95
CARE_CURR Age/sex: 15-19 Male 2016 95
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 4,260
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 142
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 2,850
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 95
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 7,347
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 237
CARE_CURR Sum of Age/Sex disaggregates 2016 237
CARE_CURR Sum of Age/Sex disaggregates 2016 237
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 7,110
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 237
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 15,128
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 488
HTS_TST Sum of Test Result disaggregates 2016 98
HTS_TST_POS By Test Result: Positive 2016 98
PP_PREV Age/sex: 15-19 Female 2016 4,092
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 4,692
PP_PREV Sum of Age/Sex disaggregates 2016 4,092
PP_PREV Total number of people in the target population 2016 216,857
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 7,347
TX_CURR Aggregated Age/Sex: 15+ Female 2016 2,697
TX_CURR Aggregated Age/Sex: 15+ Female 2016 86
TX_CURR Aggregated Age/Sex: 15+ Male 2016 1,767
TX_CURR Aggregated Age/Sex: 15+ Male 2016 57
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 4,464
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 144
TX_CURR Sum of age/sex disaggregates 2016 143
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 4,464
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 143
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 4,464
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 143
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 53
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 35
TX_NEW By Age/Sex: 15-19 Female 2016 53
TX_NEW By Age/Sex: 15-19 Male 2016 35
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 88
TX_NEW Sum of Age/Sex disaggregates 2016 88
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 88